blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1633389

EP1633389 - UNITARY COMBINATION OF FSH AND HCG [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  06.12.2019
Database last updated on 03.04.2025
Most recent event   Tooltip06.12.2019Revocation of patentpublished on 08.01.2020  [2020/02]
06.12.2019New entry: Despatch of communication that patent is revoked 
Applicant(s)For all designated states
Ferring B.V.
P.O. Box 3129 2130 KC
Polaris Avenue 144
2132 JX Hoofddorp / NL
[2013/50]
Former [2006/11]For all designated states
Ferring B.V.
P.O. Box 3129 2130 KC Polarisavenue 144
2132 JX Hoofddorp / NL
Inventor(s)01 / FILICORI, Marco
Vicolo Malgrado 2/8
I-40125 Bologna / IT
 [2006/11]
Representative(s)Bates, Philip Ian
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2013/50]Bates, Philip Ian
Reddie & Grose LLP
16 Theobalds Road
London
WC1X 8PL / GB
Former [2007/31]Bates, Philip Ian
Reddie & Grose 16 Theobalds Road
London WC1X 8PL / GB
Former [2006/11]Poulsen, Niels Jakob
Ferring Pharmaceuticals A/S, Kay Fiskers Plads 11
2300 Copenhagen S / DK
Application number, filing date04735774.402.06.2004
[2006/11]
WO2004IB01813
Priority number, dateUS2003045292603.06.2003         Original published format: US 452926
[2006/11]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004105788
Date:09.12.2004
Language:EN
[2004/50]
Type: A1 Application with search report 
No.:EP1633389
Date:15.03.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 09.12.2004 takes the place of the publication of the European patent application.
[2006/11]
Type: B1 Patent specification 
No.:EP1633389
Date:11.12.2013
Language:EN
[2013/50]
Search report(s)International search report - published on:EP09.12.2004
ClassificationIPC:A61K38/24, A61P15/08
[2006/11]
CPC:
A61K38/24 (EP,KR,US); A61P15/08 (EP); A61P5/06 (EP)
C-Set:
A61K38/24, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/11]
Extension statesLV01.12.2005
TitleGerman:EINHEINTLICHE ZUSAMMENSETZUNG ENTHALTEND FSH UND HCG[2006/11]
English:UNITARY COMBINATION OF FSH AND HCG[2006/11]
French:ASSOCIATION UNITAIRE DE FSH ET DE HCG[2006/11]
Entry into regional phase01.12.2005National basic fee paid 
01.12.2005Designation fee(s) paid 
01.12.2005Examination fee paid 
Examination procedure28.12.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
01.12.2005Examination requested  [2006/11]
15.06.2007Despatch of a communication from the examining division (Time limit: M06)
18.12.2007Reply to a communication from the examining division
22.07.2009Despatch of a communication from the examining division (Time limit: M07)
09.04.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
07.06.2010Reply to a communication from the examining division
02.09.2013Cancellation of oral proceeding that was planned for 17.09.2013
17.09.2013Date of oral proceedings (cancelled)
01.10.2013Communication of intention to grant the patent
29.10.2013Fee for grant paid
29.10.2013Fee for publishing/printing paid
Divisional application(s)EP10075419.1  / EP2292252
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.06.2007
Opposition(s)Opponent(s)01  27.08.2014    ADMISSIBLE
Merck Serono S.A.
Centre Industriel
1267 Coinsins / CH
Opponent's representative
Weiss, Wolfgang, et al, et al
Weickmann & Weickmann
Patent- und Rechtsanwälte PartmbB
Richard-Strauss-Strasse 80
81679 München / DE
 [N/P]
Former [2014/41]
Opponent(s)01  27.08.2014    ADMISSIBLE
Merck Serono S.A.
Centre Industriel
1267 Coinsins / CH
Opponent's representative
Weiss, Wolfgang, et al, et al
Weickmann & Weickmann Patentanwälte Richard-Strauss-Strasse 80
81679 München / DE
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
16.10.2014Invitation to proprietor to file observations on the notice of opposition
08.04.2015Reply of patent proprietor to notice(s) of opposition
10.06.2016Date of oral proceedings
08.07.2016Despatch of minutes of oral proceedings
08.07.2016Date of despatch of rejection of opposition
08.11.2019Legal effect of revocation of patent [2020/02]
28.11.2019Despatch of communication that the patent will be revoked
Appeal following opposition01.09.2016Appeal received No.  T2023/16
08.11.2016Statement of grounds filed
08.11.2019Result of appeal procedure: revocation of the patent
08.11.2019Date of oral proceedings
19.11.2019Minutes of the oral proceedings despatched
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
07.06.2010Request for further processing filed
07.06.2010Full payment received (date of receipt of payment)
Fees paidRenewal fee
01.12.2005Renewal fee patent year 03
26.07.2007Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
16.06.2009Renewal fee patent year 06
11.06.2010Renewal fee patent year 07
13.06.2011Renewal fee patent year 08
14.06.2012Renewal fee patent year 09
10.06.2013Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
30.06.200704   M06   Fee paid on   26.07.2007
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU02.06.2004
AT11.12.2013
BE11.12.2013
BG11.12.2013
CY11.12.2013
CZ11.12.2013
DK11.12.2013
EE11.12.2013
FI11.12.2013
MC11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SI11.12.2013
SK11.12.2013
TR11.12.2013
GR12.03.2014
PT11.04.2014
IE02.06.2014
LU02.06.2014
[2016/33]
Former [2016/32]HU02.06.2004
AT11.12.2013
BE11.12.2013
BG11.12.2013
CY11.12.2013
CZ11.12.2013
DK11.12.2013
EE11.12.2013
FI11.12.2013
MC11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SI11.12.2013
SK11.12.2013
GR12.03.2014
PT11.04.2014
IE02.06.2014
LU02.06.2014
Former [2016/28]AT11.12.2013
BE11.12.2013
BG11.12.2013
CY11.12.2013
CZ11.12.2013
DK11.12.2013
EE11.12.2013
FI11.12.2013
MC11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SI11.12.2013
SK11.12.2013
GR12.03.2014
PT11.04.2014
IE02.06.2014
LU02.06.2014
Former [2016/25]AT11.12.2013
BE11.12.2013
BG11.12.2013
CY11.12.2013
CZ11.12.2013
DK11.12.2013
EE11.12.2013
FI11.12.2013
MC11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SI11.12.2013
SK11.12.2013
PT11.04.2014
IE02.06.2014
LU02.06.2014
Former [2015/21]AT11.12.2013
BE11.12.2013
CY11.12.2013
CZ11.12.2013
DK11.12.2013
EE11.12.2013
FI11.12.2013
MC11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SI11.12.2013
SK11.12.2013
PT11.04.2014
IE02.06.2014
LU02.06.2014
Former [2015/14]AT11.12.2013
BE11.12.2013
CY11.12.2013
CZ11.12.2013
DK11.12.2013
EE11.12.2013
FI11.12.2013
MC11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SI11.12.2013
SK11.12.2013
PT11.04.2014
LU02.06.2014
Former [2015/09]AT11.12.2013
BE11.12.2013
CY11.12.2013
CZ11.12.2013
DK11.12.2013
EE11.12.2013
FI11.12.2013
MC11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SK11.12.2013
PT11.04.2014
LU02.06.2014
Former [2014/48]AT11.12.2013
BE11.12.2013
CY11.12.2013
CZ11.12.2013
DK11.12.2013
EE11.12.2013
FI11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SK11.12.2013
PT11.04.2014
Former [2014/37]AT11.12.2013
BE11.12.2013
CY11.12.2013
CZ11.12.2013
EE11.12.2013
FI11.12.2013
NL11.12.2013
PL11.12.2013
RO11.12.2013
SE11.12.2013
SK11.12.2013
PT11.04.2014
Former [2014/36]AT11.12.2013
BE11.12.2013
CY11.12.2013
EE11.12.2013
FI11.12.2013
NL11.12.2013
SE11.12.2013
Former [2014/34]AT11.12.2013
BE11.12.2013
CY11.12.2013
FI11.12.2013
NL11.12.2013
SE11.12.2013
Former [2014/26]AT11.12.2013
CY11.12.2013
FI11.12.2013
NL11.12.2013
SE11.12.2013
Former [2014/24]AT11.12.2013
FI11.12.2013
NL11.12.2013
SE11.12.2013
Former [2014/22]FI11.12.2013
NL11.12.2013
SE11.12.2013
Cited inInternational search[XD]WO0067778  (APPLIED RESEARCH SYSTEMS [NL], et al) [XD] 1,2,11-41 * page 7, line 6 - line 25; claim 15 *;
 [X]WO03022302  (APPLIED RESEARCH SYSTEMS [NL], et al) [X] 19-41 * page 11, line 28 - page 12, line 7 * * page 16, line 3 - line 17 *;
 [X]WO03022303  (APPLIED RESEARCH SYSTEMS [NL], et al) [X] 19-41 * page 19, line 6 - line 19 * * page 14, line 7 - line 31 *;
 [PX]EP1364658  (APPLIED RESEARCH SYSTEMS [AN]) [PX] 19,20,34,38-41 * page 3, line 53 - line 55; claim 24 *;
 [XDY]  - FILICORI M ET AL, STIMULATION AND GROWTH OF ANTRAL OVARIAN FILLICLES BY SELECTIVE LH ACTIVITY ADMINISTRATION IN WOMEN, JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, NEW YORK, NY, US, PAGE(S) 1156-1161, (200203), ISSN 0021-972X, XP008004363 [XD] 19-41 * page 2660, column 1 * * page 2662, column 2, paragraph 3 - page 2663, column 1, paragraph 1 * [Y] 1-18

DOI:   http://dx.doi.org/10.1210/jc.87.3.1156
 [XDY]  - FILICORI M ET AL, "LUTEINIZING HORMONE ACTIVITY SUPPLEMENTATION ENHANCES FOLLICLE-STIMULATING HORMONE EFFICACY AND IMPROVES OVULATION INDUCTION OUTCOME", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, NEW YORK, NY, US, (199908), vol. 84, no. 8, ISSN 0021-972X, pages 2659 - 2663, XP001055466 [XD] 19-41 * page 1157, column 1; table 1 * * page 1158 * [Y] 1-18

DOI:   http://dx.doi.org/10.1210/jc.84.8.2659
 [A]  - THOMPSON K A ET AL, "GONADOTROPHIN REQUIREMENTS OF THE DEVELOPING FOLLICLE", FERTILITY AND STERILITY, ELSEVIER SCIENCE INC, NEW YORK, NY, US, (199502), vol. 63, no. 2, ISSN 0015-0282, pages 273 - 276, XP001064790 [A] 1-41 * page 274, column 1, paragraph 3 *
by applicantWO8604589
    - FEVOLD ET AL., ENDOCRINOLOGY, (1940), vol. 26, page 999
    - FRAENKEL-CONRAT ET AL., PROC. SOC. EXP. BIOL. MED., (1940), vol. 45, page 627
    - MCSHAN; MEYER, J. BIOL. CHEM., (1940), vol. 135, page 473
    - GREEP ET AL., IBID, (1940), vol. 133, page 289
    - LI ET AL., SCIENCE, (1949), vol. 109, page 445
    - KEENE ET AL., J. BIOL. CHEM., (1989), vol. 26, page 4769
    - CHAPPEL ET AL., ENDOCRINE REVIEWS, (1983), vol. 4, page 179
    - SNYDER ET AL., MOL. CELL. ENDOCRIN., (1987), vol. 54, page 115
    - ZONDEK; ASCHHEIM, KLIN. WOCHENSCHR., (1928), vol. 7, page 931
    - KATZMAN ET AL., IBID, (1943), vol. 148, page 501
    - CLAESSON ET AL., ACTA ENDOCRINOL., (1948), vol. 1, page 1
    - GUPTA; DIGHE, J. MOL. ENDOCRINOLOGY, (1999), vol. 22, page 273
    - CHANG ET AL., FERTIL. STERIL., (2001), vol. 76, page 67
    - "The European Recombinant Human Chorionic Gonadotrophin Study Group", FERTIL. STERIL., (2001), vol. 75, page 1111
    - VAN HELL ET AL., ACTA ENDOCRIN., (1964), vol. 47, page 409
    - DIGHE; MOUDGAL, ARCH. BIOCHEM. BIOPHYS., (1983), vol. 225, page 490
    - ASCOLI, ENDOCRINOLOGY, (1981), vol. 108, page 88
    - REMINGTON'S PHARMACEUTICAL SCIENCES, MACK PUBLISHING CO., (1975), pages 1405 - 12,1461-
    - GOODMAN; GILMAN'S, THE PHARMACOLOGICAL BASIS FOR THERAPEUTICS
    - REMINGTON, THE SCIENCE AND PRACTICE OF PHARMACY, pages 780 - 820
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.